I know we will get a much more in depth look at what is going on with RP.
I expect extensive updates on where they are at with Flaskworks and where they are at with Direct restart, at the least.
I expect detailed updates on where the multimillion dollars a week they are spending is going.
I expect details on the results of the in vitro testing of the new immune booster agent and a path forward from there.
I expect an update on the various private clinical collaborations NWBO has partnered up on.
I suspect we may get updates on the combo trials, though as many have speculated, any real information there is likely pending MAA approval at this point so what we get may be limited.